Jatcorp (ASX:JAT) - Managing Director, Wilton Yao (centre)
Managing Director, Wilton Yao (centre)
Source: Jatcorp
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • China-Australia trade company Jatcorp (JAT) has received applications to undertake a $2.8 million placement
  • More than 148.8 million fully-paid ordinary shares will be issued to sophisticated and professional investors at 1.9 cents
  • Subject to shareholder approval, participants will receive one free-attaching option for every two shares subscribed for, exercisable at 0.6 cents on or before January 29, 2023
  • Once received, Jatcorp will use the funds to expand its ANMA manufacturing facility, develop new products and provide working capital
  • After emerging from a trading halt, shares in Jatcorp are steady on the market and are trading at 2.3 cents

China-Australia trade company Jatcorp (JAT) has received applications to undertake a $2.8 million placement.

The company entered a trading halt on Wednesday but did not disclose how much it would be raising or what the funds will be used for.

All up, 148,817,781 fully-paid ordinary shares will be issued to sophisticated and professional investors at 1.9 cents.

Furthermore, subject to shareholder approval, investors will receive one free-attaching option for every two shares subscribed for, exercisable at 0.6 cents on or before January 29, 2023.

Also subject to shareholder approval, 10 million shares will be issued to Chairman Brett Crowley to raise an additional $200,000.

Once received, Jatcorp will use the funds to expand its ANMA manufacturing facility, develop new products and provide working capital.

The ANMA facility, which is located in Melbourne, produces Jatcorp’s milk formula products.

After emerging from a trading halt, shares in Jatcorp are steady on the market and are trading at 2.3 cents at 2:25 pm AEDT.

JAT by the numbers
More From The Market Online

Cettire turbulent on $191M revenue, but no word on customs scandal

Cettire shares spiked upwards right out the gate on Friday on the same day the company…

Vitura joint venture prescribes shrooms for therapeutic use in Australian-first

In an Australian-first pharmaceutical achievement, Vitura Health Limited has announced the first ever shipment of 'shrooms'…

23% profit jump for NZ dairy co-op Fonterra

New Zealand dairy cooperative Fonterra has raised its profits 23 percent to NZ$674 million in the…

The Calmer Co’s FijiKava now at USA’s Walmart

Not long after hitting the shelves at Coles, Calmer Co's Fiji Kava products have hit the…